Sanxin Medtec: The U.S. tariff-related policies have no direct impact on the company's production and operations

Sanxin Medtec stated on the interactive platform on April 12 that, from the export perspective, the company's overseas markets mainly focus on emerging markets such as Southeast Asia, South America, and Africa. In 2024, the sales revenue from the U.S. market will account for only 0.43% of the company's total revenue, and the business exported to the U.S. market is very limited. From the import perspective, the company did not directly import products from the U.S. in 2024. Relevant policies have no direct impact on the company's production and operations